Cargando…

Twenty-four-hour effects of bimatoprost 0.01% monotherapy on intraocular pressure and ocular perfusion pressure

OBJECTIVES: To investigate the 24 h effects of bimatoprost 0.01% monotherapy on intraocular pressure (IOP) and ocular perfusion pressure (OPP). DESIGN: Prospective, open-label experimental study. SETTING: Single tertiary ophthalmic clinic. PARTICIPANTS: Sixteen patients with diagnosed primary open-a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tung, Jonathan D, Tafreshi, Ali, Weinreb, Robert N, Slight, J Rigby, Medeiros, Felipe A, Liu, John H K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Group 2012
Materias:	Ophthalmology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3951976/ https://www.ncbi.nlm.nih.gov/pubmed/22918671 http://dx.doi.org/10.1136/bmjopen-2012-001106

Ejemplares similares

Evaluating intraocular pressure-lowering solutions for the treatment of open-angle glaucoma: comparison between bimatoprost 0.03% and bimatoprost 0.01% — an observational switch study
por: Deshpande, Sarita S, et al.
Publicado: (2017)

Twenty-four-hour intraocular pressure patterns in a symptomatic patient after ab interno trabeculotomy surgery
por: Mansouri, Kaweh, et al.
Publicado: (2014)

Impact of topical bimatoprost 0.01% and bimatoprost 0.03% on conjunctival irritation in rabbits
por: Ogundele, Abayomi B, et al.
Publicado: (2010)

Aqueous humor penetration of topical bimatoprost 0.01% and bimatoprost 0.03% in rabbits
por: Ogundele, Abayomi B, et al.
Publicado: (2010)

An observational study of bimatoprost 0.01% in patients on prior intraocular pressure-lowering therapy: the Canadian Lumigan(®) RC Early Analysis Review (CLEAR) trial
por: Crichton, Andrew C, et al.
Publicado: (2014)

Intraocular Pressure Effects and Mechanism of Action of Topical Versus Sustained-Release Bimatoprost
por: Lee, Susan S., et al.
Publicado: (2019)

Aqueous humor penetration of topical bimatoprost 0.01% and bimatoprost 0.03% in rabbits: response to authors
por: Chang-Lin, Joan-En, et al.
Publicado: (2011)

Dose–Response of Intracameral Bimatoprost Sustained-Release Implant and Topical Bimatoprost in Lowering Intraocular Pressure
por: Lee, Susan S., et al.
Publicado: (2019)

Higher Intraocular Pressure Levels Associated With Lower Hysteresis In Type 2 Diabetes
por: Bekmez, Sinan, et al.
Publicado: (2018)

The Impact of Systemic Health Parameters on Intraocular Pressure in the Western Region of Saudi Arabia
por: Almarzouki, Nawaf, et al.
Publicado: (2022)

Immediate Rise in Intraocular Pressure After First-Time Intravitreal Injection of Bevacizumab
por: Mahar, Pir S, et al.
Publicado: (2023)

A combined analysis of four observational studies evaluating the intraocular pressure-lowering ability and tolerability of bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertension
por: Stevens, Annemie, et al.
Publicado: (2016)

Retrospective Analysis of Switching Bimatoprost 0.01% to Bimatoprost 0.03% in Patients with Various Types of Glaucoma and Ocular Hypertension
por: Xu, Kai Man, et al.
Publicado: (2022)

Is the observed lowering of intraocular pressure due to treatment?
por: Thomas, Ravi, et al.
Publicado: (2013)

Clinical Audit on the Effectiveness of Clinic-Based Intraocular Pressure Phasing for Patients With Glaucoma and Glaucoma Suspect
por: Nanthini, Selvaraja, et al.
Publicado: (2022)

Late-day intraocular pressure–lowering efficacy and tolerability of travoprost 0.004% versus bimatoprost 0.01% in patients with open-angle glaucoma or ocular hypertension: a randomized trial
por: DuBiner, Harvey B, et al.
Publicado: (2014)

Effects of Topical Bimatoprost 0.01% and Timolol 0.5% on Circadian IOP, Blood Pressure and Perfusion Pressure in Patients with Glaucoma or Ocular Hypertension: A Randomized, Double Masked, Placebo-Controlled Clinical Trial
por: Oddone, Francesco, et al.
Publicado: (2015)

Proposed Mechanism of Long-Term Intraocular Pressure Lowering With the Bimatoprost Implant
por: Stamer, W. Daniel, et al.
Publicado: (2023)

Longitudinal changes in intraocular pressure and association with systemic factors and refractive error: Lingtou Eye Cohort Study
por: Han, Xiaotong, et al.
Publicado: (2018)

Cannabis, Intraocular Pressure, and the Growth Arrest-Specific 7 (GAS7) Gene: A Retrospective Analysis
por: Lehrer, Steven, et al.
Publicado: (2022)

Twenty-Four-Hour Intraocular Pressure in Chronic Primary Angle-Closure Disease
por: Supakontanasan, Wasu, et al.
Publicado: (2023)

Detection of Nocturnal Elevation in Intraocular Pressure Using a Home Tonometer in a Patient With Iridocorneal Endothelial Syndrome
por: Sumi, Sayuri, et al.
Publicado: (2023)

A Study on the Association Between Myopia and Elevated Intraocular Pressure Conducted at a Tertiary Care Teaching Hospital in Gujarat, India
por: Patel, Ashka, et al.
Publicado: (2022)

Diluting 2.5% Viscoadaptive Sodium Hyaluronate to Prevent Postoperative Intraocular Pressure Rise After Phacoemulsification: A Pilot Study
por: Nusef, Aysha, et al.
Publicado: (2023)

Twenty-four-hour repeatability of diurnal intraocular pressure patterns in glaucomatous and ocular hypertensive individuals
por: Hatanaka, Marcelo, et al.
Publicado: (2011)

Effect of Intranasal Corticosteroids on Intraocular Pressure and Nerve Fiber Layer Thickness: A Cross-Sectional Study at a Tertiary Care Hospital in Western Saudi Arabia
por: Marzouki, Hani Z, et al.
Publicado: (2021)

The Comparison of Intraocular Pressure Measured by Transpalpebral Method Using Diaton and Rebound Tonometry by iCare in the Eyes Before and After Transepithelial Photorefractive Keratectomy (TPRK) in Saudi Arabia
por: Alzuhairy, Sultan
Publicado: (2022)

Reflux, Intraocular Pressure Variation and Pain Following Intravitreal Ranibizumab Injections Using 30-Gauge or 32-Gauge Needles for Patients With Retinal Pathologies: A Randomized Clinical Trial
por: Alshahrani, Saeed T, et al.
Publicado: (2021)

Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on 24-hour blood and ocular perfusion pressures: the results of a randomized trial
por: Rossetti, Luca, et al.
Publicado: (2015)

Role of prostaglandins and specific place in therapy of bimatoprost in the treatment of elevated intraocular pressure and ocular hypertension: A closer look at the agonist properties of bimatoprost and the prostamides
por: Smid, Scott D
Publicado: (2009)

A retrospective analysis of the therapeutic effects of 0.01% atropine on axial length growth in children in a real-life clinical setting
por: Kaymak, Hakan, et al.
Publicado: (2021)

Idiopathic Orbital Inflammation Treated With Rituximab Monotherapy
por: Bawazeer, Amani, et al.
Publicado: (2023)

Comparison of RCI001 and corticosteroid on the effects on intraocular pressure in mice
por: Kim, Soo Hyun, et al.
Publicado: (2023)

Twenty-Four-Hour Variation of Intraocular Pressure in Primary Open-Angle Glaucoma Treated with Triple Eye Drops
por: Itoh, Yoshinori, et al.
Publicado: (2017)

Twenty-Four-Hour Intraocular Pressure Control with Omidenepag Isopropyl 0.002% in Patients with Glaucoma and Ocular Hypertension
por: Shiratori, Naka, et al.
Publicado: (2021)

Impact of intraocular pressure on changes of blood flow in the retina, choroid, and optic nerve head in rats investigated by optical microangiography
por: Zhi, Zhongwei, et al.
Publicado: (2012)

Estimation of 24-Hour Intraocular Pressure Peak Timing and Variation Using a Contact Lens Sensor
por: Liu, John H. K., et al.
Publicado: (2015)

Twenty-Four-Hour Ambulatory Blood Pressure Monitoring
por: Pena-Hernandez, Camilo, et al.
Publicado: (2020)

Twenty-four-hour ambulatory blood pressure monitoring
por: Bugeja, Ann, et al.
Publicado: (2022)

Comparison of Two Tonometers in the Evaluation of 24-Hour Intraocular Pressure and Mean Ocular Perfusion Pressure in Patients with Thyroid-Associated Ophthalmopathy
por: Liu, Weijie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jjcenr3b4m8lm74mjn2iep7j9g